uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Kizfizo
Refused
Human
Details
EMA number
EMEA/H/C/006169
ATC code
L01AX03
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of neuroblastoma.
MeSH:
Neuroblastoma
Group:
Antineoplastic agents
Active substances
temozolomide
Marketing Authorisation Holder
ORPHELIA Pharma
MAH
Kizfizo | uMedical